The antifibrotic effect of adiponectin is mediated by inhibiting TGF-β signaling, and low levels of adiponectin are detected in dcSSc sera, in fibrotic skin areas, and specimens of pulmonary fibrosis [40, 41]. Here, ADIPOQ is linked to pulmonary fibrosis.